198 related articles for article (PubMed ID: 8083588)
21. Glycoprotein IIb/IIIa blockade inhibits platelet-mediated force development and reduces gel elastic modulus.
Carr ME; Carr SL; Hantgan RR; Braaten J
Thromb Haemost; 1995 Mar; 73(3):499-505. PubMed ID: 7667835
[TBL] [Abstract][Full Text] [Related]
22. Beta2-glycoprotein I binding to platelet microparticle membrane specifically reduces immunoreactivity of glycoproteins IIb/IIIa.
Vallar L; Regnault V; Latger-Cannard V; Lecompte T
Thromb Haemost; 2001 Feb; 85(2):314-9. PubMed ID: 11246554
[TBL] [Abstract][Full Text] [Related]
23. Analysis of platelet aggregation disorders based on flow cytometric analysis of membrane glycoprotein IIb-IIIa with conformation-specific monoclonal antibodies.
Ginsberg MH; Frelinger AL; Lam SC; Forsyth J; McMillan R; Plow EF; Shattil SJ
Blood; 1990 Nov; 76(10):2017-23. PubMed ID: 2242424
[TBL] [Abstract][Full Text] [Related]
24. Detection of an epitope specific for the dissociated form of glycoprotein IIIa of platelet membrane glycoprotein IIb-IIIa complex and its expression on the surface of adherent platelets.
Khaspekova SG; Vlasik TN; Byzova TV; Vinogradov DV; Berndt MC; Mazurov AV
Br J Haematol; 1993 Oct; 85(2):332-40. PubMed ID: 7506568
[TBL] [Abstract][Full Text] [Related]
25. Reassociation and translocation of glycoprotein IIB-IIIA in EDTA-treated human platelets.
Ma Y; Wong K
Platelets; 2007 Sep; 18(6):451-9. PubMed ID: 17763154
[TBL] [Abstract][Full Text] [Related]
26. Redistribution of alpha-granule membrane glycoprotein IIb/IIIa (integrin alpha IIb beta 3) to the surface membrane of human platelets during the release reaction.
Suzuki H; Kaneko T; Sakamoto T; Nakagawa M; Miyamoto T; Yamada M; Tanoue K
J Electron Microsc (Tokyo); 1994 Oct; 43(5):282-9. PubMed ID: 7535331
[TBL] [Abstract][Full Text] [Related]
27. Quantitation of soluble fibrinogen binding to platelets by fluorescence-activated flow cytometry.
Faraday N; Goldschmidt-Clermont P; Dise K; Bray PF
J Lab Clin Med; 1994 May; 123(5):728-40. PubMed ID: 7515093
[TBL] [Abstract][Full Text] [Related]
28. Differential inhibition of fibrinogen binding to agonist- and RGDS peptide-activated states of GPIIb-IIIa by an anti-GPIIIa monoclonal antibody, PMA5.
Nakatanl S; Hato T; Minamoto Y; Fujita S
Thromb Haemost; 1996 Dec; 76(6):1030-7. PubMed ID: 8972028
[TBL] [Abstract][Full Text] [Related]
29. Time-dependent association between platelet-bound fibrinogen and the Triton X-100 insoluble cytoskeleton.
Peerschke EI
Blood; 1991 Feb; 77(3):508-14. PubMed ID: 1899346
[TBL] [Abstract][Full Text] [Related]
30. Partial inhibition of platelet aggregation and fibrinogen binding by a murine monoclonal antibody to GPIIIa: requirement for antibody bivalency.
Kutok JL; Coller BS
Thromb Haemost; 1994 Dec; 72(6):964-72. PubMed ID: 7537915
[TBL] [Abstract][Full Text] [Related]
31. Evidence for a role of glycoprotein IIb-IIIa, distinct from its ability to support aggregation, in platelet activation by ionophores in the presence of extracellular divalent cations.
Lages B; Weiss HJ
Blood; 1994 May; 83(9):2549-59. PubMed ID: 8167340
[TBL] [Abstract][Full Text] [Related]
32. Platelet hyporeactivity in very low birth weight neonates.
Rajasekhar D; Barnard MR; Bednarek FJ; Michelson AD
Thromb Haemost; 1997 May; 77(5):1002-7. PubMed ID: 9184418
[TBL] [Abstract][Full Text] [Related]
33. High shear stress attenuates agonist-induced, glycoprotein IIb/IIIa-mediated platelet aggregation when von Willebrand factor binding to glycoprotein Ib/IX is blocked.
Iijima K; Murata M; Nakamura K; Kitaguchi T; Handa M; Watanabe K; Fujimura Y; Yoshioka A; Ikeda Y
Biochem Biophys Res Commun; 1997 Apr; 233(3):796-800. PubMed ID: 9168936
[TBL] [Abstract][Full Text] [Related]
34. Separation of the 100-kDa membrane protein mediating ADP-induced platelet shape change and activation from glycoprotein IIIa.
Colman RW; Figures WR; Wu QX; Chung SY; Morinelli TA; Tuszynski GP; Colman RF; Niewiarowski S
Trans Assoc Am Physicians; 1986; 99():39-45. PubMed ID: 3603928
[TBL] [Abstract][Full Text] [Related]
35. Complex formation of platelet membrane glycoproteins IIb and IIIa with the fibrinogen D domain.
Nachman RL; Leung LL; Kloczewiak M; Hawiger J
J Biol Chem; 1984 Jul; 259(13):8584-8. PubMed ID: 6234315
[TBL] [Abstract][Full Text] [Related]
36. Conformational modulation of purified glycoprotein (GP) IIb-IIIa allows proteolytic generation of active fragments from either active or inactive GPIIb-IIIa.
Kouns WC; Hadvary P; Haering P; Steiner B
J Biol Chem; 1992 Sep; 267(26):18844-51. PubMed ID: 1527012
[TBL] [Abstract][Full Text] [Related]
37. Monoclonal antibodies to the glycoprotein IIb-IIIa epitopes involved in adhesive protein binding: effects on platelet spreading and ultrastructure on human arterial subendothelium.
Lawrence JB; Gralnick HR
J Lab Clin Med; 1987 Apr; 109(4):495-503. PubMed ID: 2434592
[TBL] [Abstract][Full Text] [Related]
38. Calcium ions and the conformation of glycoprotein IIIa that is essential fibrinogen binding to platelets: analysis by a new monoclonal anti-GP IIIa antibody, TM83.
Yamamoto N; Kitagawa H; Yamamoto K; Tanoue K; Yamazaki H
Blood; 1989 May; 73(6):1552-60. PubMed ID: 2469495
[TBL] [Abstract][Full Text] [Related]
39. Consequences of the interaction of platelet membrane glycoprotein GPIIb-IIIa (alpha IIb beta 3) and its ligands.
Plow EF; D'Souza SE; Ginsberg MH
J Lab Clin Med; 1992 Aug; 120(2):198-204. PubMed ID: 1500819
[No Abstract] [Full Text] [Related]
40. Identification of low molecular weight GP IIb/IIIa antagonists that bind preferentially to activated platelets.
Bednar RA; Gaul SL; Hamill TG; Egbertson MS; Shafer JA; Hartman GD; Gould RJ; Bednar B
J Pharmacol Exp Ther; 1998 Jun; 285(3):1317-26. PubMed ID: 9618439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
